Functional impact of subthalamotomy by magnetic resonance–guided focused ultrasound in Parkinson’s disease: a hybrid PET/MR study of resting-state brain metabolismRodriguez-Rojas, R., Pineda-Pardo, J. A., Martinez-Fernandez, R., Kogan, R. V., Sánchez Catasùs, C., del Alamo, M., Hernandez, F., García-Cañamaque, L., Leenders, K. & Obeso, JA., 8-Nov-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 12 p.
Research output: Contribution to journal › Article › Academic › peer-review
Purpose Subthalamotomy using magnetic resonance–guided focused ultrasound (MRgFUS) has become a potential treatment option for the cardinal features of Parkinson’s disease (PD). The purpose of this study was to evaluate the effects of MRgFUS-subthalamotomy on brain metabolism using different scale levels. Methods We studied resting-state glucose metabolism in eight PD patients before and after unilateral MRgFUS-subthalamotomy using hybrid [18F]FDG-PET/MR imaging. We used statistical nonparametric mapping (SnPM) to study regional metabolic changes following this treatment and also quantified whole-brain treatment-related changes in the expression of a spatial covariance-based Parkinson’s disease–related metabolic brain pattern (PDRP). Modulation of regional and network activity was correlated with clinical improvement as measured by changes in Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) motor scores. Results After subthalamotomy, there was a significant reduction in FDG uptake in the subthalamic region, globus pallidus internus, motor and premotor cortical regions, and cingulate gyrus in the treated hemisphere, and the contralateral cerebellum (p < 0.001). Diffuse metabolic increase was found in the posterior parietal and occipital areas. Treatment also resulted in a significant decline in PDRP expression (p < 0.05), which correlated with clinical improvement in UPDRS motor scores (rho = 0.760; p = 0.002). Conclusions MRgFUS-subthalamotomy induced metabolic alterations in distributed nodes of the motor, associative, and limbic circuits. Clinical improvement was associated with reduction in the PDRP expression. This treatment-induced modulation of the metabolic network is likely to mediate the clinical benefit achieved following MRgFUS-subthalamotomy.
|Number of pages||12|
|Journal||European Journal of Nuclear Medicine and Molecular Imaging|
|Publication status||Published - 8-Nov-2019|
- Parkinson’s disease, MR-guided focused ultrasound, Subthalamotomy, Positron emission tomography, Metabolic brain network